Sign in

Maximilian Schaefer

@mmschaefer.bsky.social
367 followers 225 following 12 posts

PhD student at Merad lab @Mount Sinai | BIF PhD fellow | prev MSc at Sallusto lab, Becher lab @ETH Zürich & Apotheker @FU Berlin

PostsRepliesMedia
Maximilian Schaefer @mmschaefer.bsky.social · 10/09/2026
Excited to share our story on how SERPINs orchestrate local immunosuppressive niches in PDAC. Now out @nature.com Spearheaded by @chiarafalcomata.bsky.social 🚀 @bhavyasighs.bsky.social @brownlab1.bsky.social @miriammerad.bsky.social @sinaiimmuno.bsky.social www.nature.com/articles/s41... (1/n)
nature.com
A serpin–myeloid axis in pancreatic cancer heterogeneity and immune evasion - Nature
SERPINE1 and SERPINB2-driven fibrin-rich niches locally programme immunosuppressive macrophages and exclude T cells, enabling spatially organized immune evasion in pancreatic ductal carcinoma.
1167
Reposted by Maximilian Schaefer
Waggoner Lab @labwaggoner.bsky.social · 09/09/2026
Cancer-derived SERPINE1 and SERPINB2 are local spatial organizers of immune suppression @nature.com @chiarafalcomata.bsky.social @sinaiimmuno.bsky.social @brownlab1.bsky.social www.nature.com/articles/s41...
093
Maximilian Schaefer @mmschaefer.bsky.social · 27/07/2026
How do dendritic cells control tertiary lymphoid structures in cancer? Raphaël Mattiuz just showed us how–just out in @science.org Happy I could contribute to this important piece. @miriammerad.bsky.social www.science.org/doi/10.1126/...
science.org
Dendritic cells control tertiary lymphoid structure development and maintenance in cancer
Tertiary lymphoid structures (TLSs) are associated with immunotherapy response, yet the mechanisms controlling their formation and maintenance remain unclear. Using spatial transcriptomics and multipl...
0184
Reposted by Maximilian Schaefer
Ingelfinger Lab @ingelfingerlab.bsky.social · 08/06/2026
hello world. Excited to launch the Ingelfinger Lab account! We’re a young lab in Germany’s Black Forest tackling key questions in immunology with innovative single-cell technologies. Follow us for updates on systems immunology, machine learning & translational oncology. fi
0165
Reposted by Maximilian Schaefer
NY-CURES @nycures.bsky.social · 24/11/2025
📢 SIGN & SHARE THE PETITION! 📢 New York needs an Empire Biomedical Research Institute to create new statewide funding opportunities for scientists & physician-scientists so that patients and their families get the life-saving and life-changing new therapeutics they're hoping for ✏️ c.org/TDMy2H9JTW
c.org
Sign the Petition
Support a New York State Biomedical Institute for a Healthier, More Affordable Future
13938
Maximilian Schaefer @mmschaefer.bsky.social · 15/08/2025
Thrilled our Perspective in @nataging.nature.com is out! With Matthew D Park et al., we spotlight how aging reshapes RTMs and skews myelopoiesis–with consequences for healthy aging and cancer @miriammerad.bsky.social www.nature.com/articles/s43...
nature.com
Restoring resident tissue macrophages to combat aging and cancer - Nature Aging
Park and colleagues propose a conceptual framework in which dysregulation of resident tissue macrophages is both a central contributor to how an aging immune system causes diseases, including cancer, ...
030
Maximilian Schaefer @mmschaefer.bsky.social · 20/06/2025
New preprint out! 🚀Spearheaded by @chiarafalcomata.bsky.social we could show how pancreatic cancer cells evade the immune system by modulating their TME with the extracellular factors Serpine1 (PAI-1) and Serpinb2 (PAI-2)! #PertrubMap #PDAC
020
Reposted by Maximilian Schaefer
BrownLab @Mt.Sinai @brownlab1.bsky.social · 15/01/2025
First lab Bluesky post! Happy to share new papers: PRINT: Using Perturb-map, we show in @cellpress.bsky.social how ovarian tumors resist immunotherapy > www.cell.com/cell/abstrac... PREPRINT We developed a new technology to easily generate cell-targeted LNP-RNA > www.biorxiv.org/content/10.1...
cell.com
Ovarian cancer-derived IL-4 promotes immunotherapy resistance
Cancer-derived paracrine factors create distinct “neighborhoods” in the tumor microenvironment, promoting clonal selection and tumor heterogeneity. In ovarian cancer, IL-4 originating from a minority ...
0139
Reposted by Maximilian Schaefer
Miriam Merad @miriammerad.bsky.social · 27/01/2025
Very honored to be inducted at the Belgian Royal Academy of Medicine this weekend alongside incredible colleagues. Thank you again to the Academy for honoring my laboratory. It was also refreshing to spend time with like-minded peers amidst all the chaos,
4276
Reposted by Maximilian Schaefer
Tcellogic (Sue Kaech) @tcellogic.bsky.social · 14/12/2024
Here is link to Shixin's new paper: www.science.org/doi/epdf/10....
science.org
Nutrient-driven histone code determines exhausted CD8+ T cell fates
ACLY-deficient CAR T cells targeting the tumor-associated antigen disialoganglioside GD2 (GD2 CAR T cells) also resisted acquiring TEX-like properties, exhibiting reduced CD39 expression when co-cultu...
510932
Reposted by Maximilian Schaefer
Anna Obenauf @obenaufa.bsky.social · 27/11/2024
1/23 Big news for the #ObenaufLab! So excited to finally share our new study providing another puzzle piece, why immunotherapy fails in many tumors, now out in @Nature 🧵👇 www.nature.com/articles/s41...
47559142